Mateon and PointR Data merge to form artificial intelligence driven immuno-oncology company

Mateon Therapeutics (OTCQB:MATN) and PointR Data Inc., enter into a definitive agreement with respect to a merger, creating a publicly traded …

Link to Full Article: Read Here